Medigen Biotechnology Corporation

For profitWebsite ↗

Also known as: Medigen Biotechnology Corporation | Medigen, Inc. | Medigen Vaccine Biologics | Medigen Vaccine Biologics Corp. | Medigen Vaccinology Corp.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 4

First clinical trial

Jul 1, 2001

Last known activity

Aug 15, 2025

Timeline

1990s

Jun 1, 1999
Medigen Biotechnology Corporation— Founded

Drugs by trial phase (20 distinct, 31 trials)

Phase 4 (1 own, 0 via acquisition)

mvc-cov1901

Phase 3 (4 own, 0 via acquisition)

Phase 2 (11 own, 0 via acquisition)

Phase 1 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (37)

NCT07088822Lead sponsorPhase 1Aug 15, 2025
NCT07178522Lead sponsorPhase 3Jun 25, 2025
NCT06730009Lead sponsorPhase 1/Phase 2Oct 21, 2024
NCT06730009OfficialPhase 1/Phase 2Oct 21, 2024
NCT05198596Lead sponsorPhase 3Jul 30, 2022
NCT05198596Study directorPhase 3Jul 30, 2022
NCT05426343Study directorPhase 3Jul 9, 2022
NCT05426343Lead sponsorPhase 3Jul 9, 2022
NCT05216601Lead sponsorPhase 1May 6, 2022
NCT05216601Study directorPhase 1May 6, 2022
NCT05394714Study chairPhase 1Mar 10, 2022
NCT05394714Lead sponsorPhase 1Mar 10, 2022
NCT05197153Study chairPhase 2Jan 22, 2022
NCT05197153Lead sponsorPhase 2Jan 22, 2022
NCT05132855CollaboratorPhase 1Nov 30, 2021

Details

Founded: Taipei, TW Jun 1, 1999
Last known activity: Aug 15, 2025